A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
about
Immunological Evasion in GlioblastomaImmunotherapy for cancer in the central nervous system: Current and future directionsNovel immunotherapeutic approaches for the treatment of acute leukemia (myeloid and lymphoblastic)Overview of current immunotherapeutic strategies for gliomaBiomarkers for glioma immunotherapy: the next generationImmunotherapy advances for glioblastomaTargeting the innate immune system as immunotherapy for acute myeloid leukemiaImmunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?Antibody-based immunotherapy for malignant glioma.Durable therapeutic efficacy utilizing combinatorial blockade against IDO, CTLA-4, and PD-L1 in mice with brain tumors.Trial Watch: Peptide-based anticancer vaccines.Neem leaf glycoprotein activates CD8(+) T cells to promote therapeutic anti-tumor immunity inhibiting the growth of mouse sarcomaImmunotherapy for malignant gliomaPI3K pathway inhibitors: potential prospects as adjuncts to vaccine immunotherapy for glioblastoma.Immunosuppressive mechanisms in glioblastoma.Impact of temozolomide on immune response during malignant glioma chemotherapySerum elevation of B lymphocyte stimulator does not increase regulatory B cells in glioblastoma patients undergoing immunotherapy.Immunotherapy in pediatric malignancies: current status and future perspectivesRegulatory T cells move in when gliomas say "I Do".Impact of anti-CD25 monoclonal antibody on dendritic cell-tumor fusion vaccine efficacy in a murine melanoma model.Immunotherapy in glioblastoma: emerging options in precision medicinePrioritization schema for immunotherapy clinical trials in glioblastoma.Immune-checkpoint blockade and active immunotherapy for glioma.Targeting Tregs in Malignant Brain Cancer: Overcoming IDO.Immune evasion in acute myeloid leukemia: current concepts and future directions.Microenvironmental clues for glioma immunotherapy.Phenotypic alterations, clinical impact and therapeutic potential of regulatory T cells in cancer.A new hope in immunotherapy for malignant gliomas: adoptive T cell transfer therapy.Vaccine-based immunotherapy for glioblastoma.Vaccine therapies for patients with glioblastoma.The targeting of indoleamine 2,3 dioxygenase -mediated immune escape in cancer.Peptide vaccines for the treatment of glioblastoma.The role of regulatory T cells and microglia in glioblastoma-associated immunosuppression.Vaccination strategies for neuro-oncology.Targeting regulatory T cells in tumors.Developing immunotherapeutic strategies to target brain tumors.Immunological effects of chemotherapy and radiotherapy against brain tumors.Vaccine strategies for the treatment of lymphoma: preclinical progress and clinical trial update.Depletion of regulatory T cells in a mouse experimental glioma model through anti-CD25 treatment results in the infiltration of non-immunosuppressive myeloid cells in the brain.Leveraging chemotherapy-induced lymphopenia to potentiate cancer immunotherapy.
P2860
Q26746612-1B27A6EB-7ECC-4A1B-9398-FFCAE3DF819CQ26750765-DA5A7760-8D5F-4B92-83DB-B4117C6F48E3Q26770391-B9548E58-68BB-4CAA-B30D-923CE7DA66F3Q26776345-B43A4320-3356-41F8-8909-914A5214AC81Q26825496-1AE15189-85DA-47C4-A7D0-8541C100570EQ26866513-1C120F68-AECE-4F8C-A1E5-1BBC4BCEED7AQ27015876-3815B468-C0D9-4E0C-BFD3-9E35CC4B650AQ28078539-B23D427C-44E5-4471-98F8-435895ABD1D3Q34120472-99CC34C8-5B9A-499A-9C97-F5E4A90E2829Q34276759-C86DDEAE-C7EF-4CA8-860D-A3594AF45EAEQ34483345-B0FE7E88-6515-4EA6-86BA-721B56067B32Q34550822-287E2933-FC1E-4164-8800-9F5B233E4DE5Q35114086-EB10FC27-07A1-43F5-A832-0B4C9CD5F51EQ36086507-B807ABE4-5BEB-4A94-8E8E-0CD27B163469Q36224048-43D28552-7A74-426A-BD48-FE387E125701Q36362798-B4ADCFA7-445D-4874-87B1-4E0D8717935FQ36558234-5A2F7AEA-6054-49C2-BAC9-B74F8F023941Q36691818-8956A502-A52E-4F31-8992-431C65420C68Q36872066-AC5969AE-1914-4CD1-9A2B-3EA2D377AB6BQ36952541-8EABDF0C-17E6-4432-B2AD-49DF2869030DQ37050960-8FB5E922-E905-473C-A535-348EF6B0D3EFQ37078999-A9607593-7A1B-4A82-8882-0E05766F1BD6Q37420586-E1780815-3ACC-45E2-A118-6B9E0E8EC070Q38110540-903B720E-AECD-414E-9623-1557847FEFCDQ38172521-0BC5F305-CA8C-4A23-8474-0432002825A2Q38194054-606B8D65-304A-4EA4-B716-BAF45E83656AQ38198735-D187D957-857A-49D7-8F26-EDA34D852274Q38227889-38119FEC-C20B-48BF-885B-BAD7CFDC5F76Q38233114-7A8B5964-2E06-4912-BC30-7A1DA11CA189Q38243975-220ADA5F-2A89-4B8D-BC09-5B5A97DE4ADEQ38248051-DA6675F0-6197-47E1-B2A5-5EB62736BFD9Q38285889-5C139A01-1967-4895-84A6-227A50EE4AD2Q38540262-F701292A-7B56-4297-B9C1-AC303EDFD5BCQ38620079-243F257E-0F9D-42B8-A574-89A004994745Q38703565-D678B0E9-86BD-408C-83CB-EB6B1C07ECE0Q38851464-5F4FC741-F6FA-4D49-BC64-498DC7494321Q38947116-C8FA87A0-73DF-48FA-BF60-FF96E364FDCDQ39043404-B949F240-CF69-48DE-A181-57226B39BD57Q40752470-9EC68BD9-C639-4BF6-8E90-883336E40C93Q43103859-FD544FE9-F16B-4C0C-B65D-C4AAF7DD45C0
P2860
A pilot study of IL-2Rα blockade during lymphopenia depletes regulatory T-cells and correlates with enhanced immunity in patients with glioblastoma
description
2012 nî lūn-bûn
@nan
2012 թուականին հրատարակուած գիտական յօդուած
@hyw
2012 թվականին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@ast
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@en
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@nl
type
label
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@ast
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@en
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@nl
prefLabel
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@ast
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@en
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@nl
P2093
P2860
P50
P3181
P1433
P1476
A pilot study of IL-2Rα blocka ...... in patients with glioblastoma
@en
P2093
Duane A Mitchell
Elizabeth A Reap
Gary E Archer
James E Herndon
James J Vredenburgh
John H Sampson
Kendra L Congdon
Robert J Schmittling
Smita K Nair
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0031046
P407
P50
P577
2012-01-01T00:00:00Z